Blueberries MedicalBBRRF EV-to-FCF is -11.80 as of Jul. 01, 2026. The stock has 2 warning signs investors should review. Among 560 Drug Manufacturers companies, Blueberries Medical ranks worse than 178571.25% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Blueberries Medical's Enterprise Value is $3.58 Mil.
Blueberries Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.30 Mil. Therefore, Blueberries Medical's EV-to-FCF for today is -11.80.
The historical rank and industry rank for Blueberries Medical's EV-to-FCF or its related term are showing as below:
BBRRF'
s EV-to-FCF Range Over the Past 10 Years
Min: -12.17 Med: -3.78 Max: -1.22
Current: -11.8
During the past 13 years, the highest EV-to-FCF of Blueberries Medical was -1.22. The lowest was -12.17. And the median was -3.78.
BBRRF's EV-to-FCF is ranked worse than 100% of 560
companies
in the Drug Manufacturers industry
Industry Median: 20.52
vs BBRRF: -11.80
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Blueberries Medical (OTCPK:BBRRF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Blueberries Medical's PE Ratio (TTM) for today is calculated as:
Blueberries Medical's share price for today is $0.0107.
Blueberries Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Blueberries Medical EV-to-FCF Related Terms
Blueberries Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Blueberries Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueberries Medical EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Blueberries Medical's EV-to-FCF falls into.
Blueberries Medical's current Enterprise Value is $3.58 Mil.
Blueberries Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blueberries Medical (BBRRF) has a EV-to-FCF of -11.80 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Blueberries Medical and its competitors. According to the industry distribution chart, Blueberries Medical ranks #999999 out of 560 companies in the Drug Manufacturers industry.
Is Blueberries Medical's EV-to-FCF too high?
Blueberries Medical's current EV-to-FCF is -11.80. Based on the distribution chart, Blueberries Medical ranks #999999 out of 560 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Blueberries Medical's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #999999 out of 560 companies for EV-to-FCF. This places Blueberries Medical in the lower half of its industry. The industry median EV-to-FCF is 20.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.52, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Blueberries Medical and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueberries Medical's current EV-to-FCF is -11.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current EV-to-FCF of -11.80. The current EV-to-FCF is -11.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current EV-to-FCF is -11.80 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBRRF has been successfully added to your 